GMO argues international deep value equities remain one of the most compelling opportunities globally, despite strong recent performance, as valuation gaps versus the U.S. stay historically wide.
If value has already outperformed, why is it still cheap? GMO’s answer is simple: the re-rating may only be halfway through.
Die Registrierung dauert weniger als 1 Minute.
Keine Zahlungsdaten erforderlich